Epstein Barr Virus by In-Situ HybridizationTest Code I EBER ISH Associations Infectious mononucleosis, Burkitt's lymphoma,Reed Sternberg cells Hodgkin's lymphoma, nasopharyngeal carcinoma, HIV infection Methodology Chromogenic in-situ Hybridization (CISH) CPT Codes 88368 - Morphometric analysis, in situ hybridization Turnaround Time Less than 2 days Specimen Requirements
Specimen Stability Prepared pathology materials, stable indefinitely at 18-25°C Storage & Handling Ship samples at ambient temperature. Causes for Rejection Improper specimen labeling; Inadequate tissue evaluation; Improper sample submission Reference Range EBER by ISH is performed on formalin-fixed paraffin-embedded tissues and the result is very similar to the traditional IHC slide - a brown (DAB) chromogen target location on a Hematoxylin counter-stained slide. Description EBV infection is associated with a variety of pathological conditions. The virus has been reported to be demonstrated in infectious mononucleosis, Burkitt's lymphoma, the Reed Sternberg cells of Hodgkin's disease and in nasopharyngeal carcinoma. In HIV infection, EBV has also been reported to be demonstrated in primary CNS lymphomas and oral hairy leukoplakia lesions. The technique demonstrates cells latently-infected with EBV as it hybridizes to abundantly expressed Epstein-Barr virus-encoded RNA (EBER) transcripts which are concentrated in the nuclei of latently-infected cells. |
Search DirectoryDirectory |